A detailed history of High Point Advisor Group LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, High Point Advisor Group LLC holds 2,100 shares of JAZZ stock, worth $258,237. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,100
Previous 2,054 2.24%
Holding current value
$258,237
Previous $219,000 6.85%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$100.57 - $116.37 $4,626 - $5,353
46 Added 2.24%
2,100 $234,000
Q2 2024

Aug 08, 2024

BUY
$103.94 - $118.98 $9,666 - $11,065
93 Added 4.74%
2,054 $219,000
Q1 2024

May 14, 2024

SELL
$115.19 - $132.77 $3,455 - $3,983
-30 Reduced 1.51%
1,961 $236,000
Q4 2023

Mar 26, 2024

BUY
$114.26 - $136.0 $227,491 - $270,776
1,991 New
1,991 $244,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track High Point Advisor Group LLC Portfolio

Follow High Point Advisor Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.